3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
5
Observational
2
Sponsor
Cancer Type
Dermatologic
2
Conditions
Carcinoma, Basal Cell
2
Neoplasms, Basal Cell
1
Eyelid Neoplasms
1
Interventions
Blood Specimen Collection
131
Surveys and Questionnaires
130
Specimen Handling
57
Observation
55
Radiotherapy
44
Interviews as Topic
34
Surgical Procedures, Operative
32
Drug Therapy
31
Biopsy
28
Data Collection
26
Magnetic Resonance Spectroscopy
25
Nivolumab
20
Watchful Waiting
20
Immune Checkpoint Inhibitors
18
Immunotherapy
17
Magnetic Resonance Imaging
17
Therapeutics
17
Standard of Care
16
trastuzumab deruxtecan
14
Liquid Biopsy
13
Tomography, X-Ray Computed
13
palbociclib
13
Hematologic Tests
12
Restraint, Physical
12
Focus Groups
11
Genetic Testing
11
Bevacizumab
10
Positron Emission Tomography Computed Tomography
10
darolutamide
10
enzalutamide
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
sonidegib
×
1 year
×
Clear all
NCT04066504
2026-03-18
NISSO
Sun Pharmaceutical Industries Limited
Completed
323 enrolled
NCT07068568
2025-07-16
BCC-Sonidegib
Federico II University
Completed
12 enrolled